Table 5.

Expression status of SOX2-OT in various cancers.

Expression status	Cancer	Reference
Increased	Lung cancer	Hou et al. [34], Zhang et al. [62], Jazi et al. [91]
Decreased	Gastric cancer	Farhangian et al. [92]
Increased	Gastric cancer	Zou et al. [37], Zhang et al. [36], Wei et al. [63], Qu et al. [64]
Increased	Esophageal cancer	Aliereza et al. [93], Tian et al. [23], Wu et al. [15]
Increased	Breast cancer	Iranpour et al. [94], Tang et al. [31]
Increased	Hepatocellular carcinoma	Sun et al. [42], Shi et al. [35]
Increased	Ovarian cancer	Han et al. [95]
Increased	Pancreatic ductal adenocarcinoma	Li et al. [18], Zhang et al. [19]
Increased	Cholangiocarcinoma	Li et al. [40], Wei et al. [57]
Increased	Osteosarcoma	Wang et al. [38]
Increased	Laryngeal squamous cell carcinoma	Tai et al. [24], Feng et al. [96]
Increased	Nasopharyngeal carcinoma	Zhang et al. [59]
Increased	Glioblastoma	Wang et al. [25]
Increased	Bladder cancer	Zhan et al. [17]
Increased	Prostate cancer	Wo et al. [60]
Increased	Ewing's sarcoma	Ma et al. [61]
Increased	Colorectal cancer	Liu et al. [97]